Pharmaceutical Care Management Association (PCMA)
Registered Principal Details
Business Or Interest:
Pharmacy Benefits Management
Lobbying Interests:
Primarily pharmacy benefits management, including health care, insurance, pharmaceuticals and state budget matters as they relate to PBMs
CEO Name:
JC Scott
Pharmacy Benefits Management
Lobbying Interests:
Primarily pharmacy benefits management, including health care, insurance, pharmaceuticals and state budget matters as they relate to PBMs
CEO Name:
JC Scott
Contact
HC
Heather Cascone
325 7th Street NW, 9th Fl
Washington, DC 20004
(202) 744-8416
hcascone@pcmanet.org
http://www.pcmanet.org
325 7th Street NW, 9th Fl
Washington, DC 20004
(202) 744-8416
hcascone@pcmanet.org
http://www.pcmanet.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 7
Relating to: pharmacy benefit managers, prescription drug benefits, and granting rule-making authority. (FE)
Bill Text and History
8/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
Comments as to effective date of the bill only
Relating to: pharmacy benefit managers, prescription drug benefits, and granting rule-making authority. (FE)
Bill Text and History
Other
Notification Date8/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
Comments as to effective date of the bill only
Assembly Bill 184
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
2/7/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
Against
Notification Date2/7/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 718
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
Bill Text and History
2/7/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
Bill Text and History
Against
Notification Date2/7/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 745
Relating to: prohibiting step therapy protocols for certain cancer drugs.
Bill Text and History
2/7/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prohibiting step therapy protocols for certain cancer drugs.
Bill Text and History
Against
Notification Date2/7/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 753
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
Bill Text and History
1/19/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
Bill Text and History
Against
Notification Date1/19/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2021 January - June $108.17 |
2021 July - December $1,406.21 |
2022 January - June $39,598.00 |
2022 July - December $28,836.34 |
Total $69,948.72 |
| Total Hours Communicating | 2021 January - June 1.00 |
2021 July - December 0.00 |
2022 January - June 1.50 |
2022 July - December 0.50 |
Total 3.00 |
| Total Hours Other | 2021 January - June 0.00 |
2021 July - December 13.00 |
2022 January - June 22.50 |
2022 July - December 86.50 |
Total 122.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: pharmacy benefit managers, prescription drug benefits, and granting rule-making authority. (FE)
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 100% |
2021 July - December |
2022 January - June |
2022 July - December |
Total < 1% |
Relating to: prohibiting step therapy protocols for certain cancer drugs.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 5% |
2022 July - December |
Total < 1% |
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 10% |
2022 July - December 5% |
Total 5% |
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 40% |
2022 July - December 45% |
Total 39% |
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 45% |
2022 July - December 50% |
Total 44% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication